EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent progress in cancer multidrug resistance and therapeutic options associated with protein damage response

Fangyuan Shao iD, Dongyang Tang iD, Ling Li iD, Xiaoling Xu, Chu-Xia Deng iD

Protein & Cell · 01.11.2026 · 17 (11) · 1001-1020

DOI: 10.1093/procel/pwag032 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Protein & Cell, online erschienen am 23.06.2026. Verfasst von Fangyuan Shao und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Center, Faculty of Health Sciences, University of Macao, Taipa, Macao 999078, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Drug Resistance, Multiple, Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Development Fund, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multidrug resistance (MDR) is a common and leading cause of treatment failure and mortality in cancer patients. While numerous biological processes contribute to drug resistance, recent studies have revealed that most anticancer drugs rapidly bind to and damage newly synthesized proteins upon entering cells. This process, termed acute drug protein damage (ADPD), occurs before the drugs act on their canonical targets. To evade the lethal effects of ADPD, cancer cells rapidly initiate a series of protective responses collectively termed the protein damage response (PDR). This cascade includes damage recognition via protein ubiquitination, damage clearance through the proteasome system, and subsequent mitophagy to remove damaged mitochondria caused by the co-import of drugs and damaged proteins. Here, we review the current understanding of multiple biological processes underlying drug resistance, with a focus on the mechanisms of ADPD induced by anticancer drugs, the pivotal role of PDR in driving MDR, and its potential applications in predicting and overcoming drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug Resistance, NeoplasmDrug Resistance, MultipleNeoplasmsAntineoplastic AgentsHumansAnimalsMitophagyMitochondriaProteasome Endopeptidase ComplexUbiquitination

Stichwörter der Autor:innen

acute drug protein damagemitochondriamitophagymultidrug resistanceprotein damage response

Substanzen

Antineoplastic AgentsProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Cancer Center, Faculty of Health Sciences, University of Macao, Taipa, Macao 999078, China.
  • Center for Precision Medicine Research and Training, Faculty of Health Sciences, University of Macao, Taipa, Macao 999078, China.
  • MoE Frontiers Science Center for Precision Oncogene, University of Macao, Taipa, Macao 999078, China.
  • University of Macao Advanced Research Institute in Hengqin, Zhuhai 519031, China.
  • Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen 518107, China.

ORCID-Profile: Fangyuan Shao, Dongyang Tang, Ling Li, Chu-Xia Deng

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Development Fund
  • Guangdong Basic and Applied Basic Research Foundation

Zitieren

APA

Shao, F., Tang, D., Li, L., Xu, X., & Deng, C. X. (2026). Recent progress in cancer multidrug resistance and therapeutic options associated with protein damage response. Protein & Cell, 17(11), 1001-1020. https://doi.org/10.1093/procel/pwag032

Vancouver

Shao F, Tang D, Li L, Xu X, Deng CX. Recent progress in cancer multidrug resistance and therapeutic options associated with protein damage response. Protein & Cell. 2026;17(11):1001-1020. doi:10.1093/procel/pwag032

BibTeX
@article{Shao2026,
  author = {Shao, Fangyuan and Tang, Dongyang and Li, Ling and Xu, Xiaoling and Deng, Chu-Xia},
  title = {Recent progress in cancer multidrug resistance and therapeutic options associated with protein damage response},
  journal = {Protein & Cell},
  year = {2026},
  volume = {17},
  number = {11},
  pages = {1001--1020},
  doi = {10.1093/procel/pwag032}
}
Kostenlos starten →